Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hip Fracture Patient and the Use of IndwElling vs IntermittEnt Catheterization Pilot Study

NCT05354921 is registered in ClinicalTrials.gov with Ottawa Hospital Research Institute as lead sponsor.

NCT NCT05354921
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05354921 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hip Fracture Patient and the Use of IndwElling vs IntermittEnt Catheterization Pilot Study
Lead sponsor
Ottawa Hospital Research Institute
Phase
Not applicable
Overall status
Unknown status
Start date
June 30, 2022
Completion date
July 31, 2023
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

catheter complications, hip fractures, urinary tract infections, urogenital